News

John Theurer Cancer Center Enrolls First Two Patients Nationwide for Groundbreaking Phase II Clinical Trial for Glioblastoma

Physicians at the John Theurer Cancer Center at Hackensack Meridian Health Hackensack University Medical Center have enrolled the first two patients nationwide in an international phase II clinical trial of Kazia Therapeutics’s novel therapy, GDC-0084, for glioblastoma.

READ FULL PRESS RELEASE ON HACKENSACKMERIDIANHEALTH.ORG